Eledon exchanges 4.2M shares for pre-funded warrant with Coastlands

Eledon Pharmaceuticals, Inc.

Exchange of 4,203,764 common shares for pre-funded warrant at $0.001 exercise price.
Warrant has 4.99% beneficial ownership limitation, can be increased to 19.99% per Nasdaq rules.
Issued under Section 3(a)(9) exemption; exchange closed December 30, 2025.
Counterparty: Coastlands Capital Partners LP.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.